| abstract |
The present invention relates to: (a) compounds and salts thereof which inter alia inhibit HCV; (b) intermediates useful in the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) preparation of such compounds and salts; Intermediates, compounds, salts and compositions; (e) methods of using such compounds, salts and compositions; and (f) kits comprising such compounds, salts and compositions. |